ARCHIVES

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

This article is from The Cancer Letter archive.

Vol. 31 No. 43 | November 23, 2005

Download PDF Visit The Full Archive

Related Articles

MD Anderson Completes $500 Million Research Endowment

September 24, 2010

Cancer Control Survey Determines Manpower Needs for Quality Care

July 9, 1976

Suspect Chemical Include Castor Oil, Witchhazel; Details On 38 Picked For Long Term Tests

August 5, 1977

NCI’s Oral Cancer Chemoprevention Trial On Hold After Fraud Allegations In Norway.

January 27, 2006

Prostate Ultrasound Markers Concepts Approved by BSC

October 3, 1986

NIH Panel Calls For More Attention to Cancer Pain

July 26, 2002